MLTX - MoonLake Immunotherapeutics

QQQ $ 454.82 $ 1.73 (0.38 %)

DIA $ 398.57 $ -2.04 (-0.52 %)

SPY $ 530.36 $ 0.37 (0.07 %)

TLT $ 91.26 $ -1.31 (-1.43 %)

GLD $ 225.37 $ 2.27 (1.05 %)

Previous Close

$ 41.7

Open

$ 41.42

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 40.11 - $ 41.74

52 Week Range

$ 24.31 - $ 64.98

Volume

246,703

Average Volume

Market Cap

5.22B

Beta (5Y Monthly)

$ 0.66

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-07-2024	03-31-2024	10-Q
2	02-29-2024	12-31-2023	10-K
3	11-14-2023	09-30-2023	10-Q
4	08-10-2023	06-30-2023	10-Q
5	05-11-2023	03-31-2023	10-Q
6	03-20-2023	12-31-2022	10-K
7	11-14-2022	09-30-2022	10-Q
8	08-12-2022	06-30-2022	10-Q
9	05-16-2022	03-31-2022	10-Q
10	02-17-2022	12-31-2021	10-K
11	11-12-2021	09-30-2021	10-Q
12	08-16-2021	06-30-2021	10-Q
13	05-21-2021	03-31-2021	10-Q
14	03-31-2021	12-31-2020	10-K
15	12-03-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Moon...
05/17/2024 14:17:36

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates MoonLake (NASDAQ:MLTX) with a Buy and maintains $100 price tar...

Moonlake Immunotherapeutics Begins Phase 3...
05/16/2024 12:10:32

MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidrad...

why-diodes-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Why Diodes Shares Are Trading Lower By Aro...
05/10/2024 16:44:44

HC Wainwright & Co. Reiterates Buy on Moon...
05/08/2024 19:16:24

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates MoonLake (NASDAQ:MLTX) with a Buy and maintains $100 price tar...

Needham Reiterates Buy on MoonLake, Mainta...
05/08/2024 09:53:17

Needham analyst Serge Belanger reiterates MoonLake (NASDAQ:MLTX) with a Buy and maintains $66 price target.

MoonLake Q1 EPS $(0.22) Misses $(0.20) Est...
05/07/2024 12:09:48

MoonLake (NASDAQ:MLTX) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.20) by...

HC Wainwright & Co. Reiterates Buy on Moon...
04/23/2024 10:26:47

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates MoonLake (NASDAQ:MLTX) with a Buy and maintains $100 price tar...

HC Wainwright & Co. Reiterates Buy on Moon...
04/11/2024 11:27:28

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates MoonLake (NASDAQ:MLTX) with a Buy and maintains $100 price tar...

Moonlake Immunotherapeutics Penned Three-y...
04/10/2024 11:06:15

Needham Reiterates Buy on MoonLake, Mainta...
04/09/2024 09:57:39

Needham analyst Serge Belanger reiterates MoonLake (NASDAQ:MLTX) with a Buy and maintains $66 price target.

Goldman Sachs Initiates Coverage On MoonLa...
04/02/2024 11:05:50

Goldman Sachs analyst Richard Law initiates coverage on MoonLake (NASDAQ:MLTX) with a Neutral rating and announces Price Tar...

Watching MoonLake Immunotherapeutics; Shar...
03/28/2024 16:02:13

https://www.betaville.co.uk/betaville-intelligence/uncooked-alert-moonlake-immunotherapeutics-said-to/

Wedbush Reiterates Outperform on MoonLake,...
03/13/2024 13:27:00

Wedbush analyst Andreas Argyrides reiterates MoonLake (NASDAQ:MLTX) with a Outperform and maintains $92 price target.

why-is-inflammatory-disease-focused-moonlake-immunotherapeutics-stock-trading-higher-today

Why Is Inflammatory Disease-Focused MoonLa...
03/11/2024 13:56:06

Results with MoonLake Immunotherapeutics' Nanobody sonelokimab in Psoriatic Arthritis. Achieve over 60% ACR50, 40% ACR70, a...

Wedbush Reiterates Outperform on MoonLake,...
03/11/2024 12:48:29

Wedbush analyst Andreas Argyrides reiterates MoonLake (NASDAQ:MLTX) with a Outperform and maintains $92 price target.

HC Wainwright & Co. Maintains Buy on MoonL...
03/11/2024 11:17:04

HC Wainwright & Co. analyst Raghuram Selvaraju maintains MoonLake (NASDAQ:MLTX) with a Buy and raises the price target f...

Needham Reiterates Buy on MoonLake, Mainta...
03/11/2024 10:46:26

Needham analyst Serge Belanger reiterates MoonLake (NASDAQ:MLTX) with a Buy and maintains $66 price target.

Sunday, MoonLake Immunotherapeutics Said C...
03/11/2024 09:15:10

Moonlake Immunotherapeutics To Present Mir...
03/04/2024 13:04:02

MoonLake Immunotherapeutics to present MIRA trial data of Nanobody® sonelokimab in hidradenitis suppurativa as a late breaker a...

HC Wainwright & Co. Reiterates Buy on Moon...
03/04/2024 12:45:24

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates MoonLake (NASDAQ:MLTX) with a Buy and maintains $75 price target.